NCT06282783View on ClinicalTrials.gov

Studying Topiramate for Re-Activating the HIV-1 Reservoir

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

August 31, 2025

Conditions
HIV-1-infectionHivHIV InfectionsHIV I Infection
Interventions
DRUG

Topiramate

Single dose of 400mg

Trial Locations (1)

Unknown

Erasmus Medical Centre, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER